Patents by Inventor Shigekazu Nakatsugawa

Shigekazu Nakatsugawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115179
    Abstract: Provided is an electrode member 1 to be attached to a body surface of a user, and includes an adhesion part 2 including a through hole 23 near a center and capable of adhering to a body surface of a user, an electrode 3 inserted into the through hole of the adhesion part, and a first retention part 4A configured to retain a solution for dissolving sebum C, in which a flow channel R including a gap is formed between an inner peripheral surface of the through hole of the adhesion part and the electrode, and the solution for dissolving sebum retained in the first retention part is able to flow out from one end side of the through hole through the flow channel.
    Type: Application
    Filed: February 1, 2022
    Publication date: April 11, 2024
    Inventor: Shigekazu NAKATSUGAWA
  • Publication number: 20240049811
    Abstract: A garment system includes: a garment that is worn by a user; a blower unit that blows air toward the garment; and a control device that controls the blower unit, wherein the garment is divided into a plurality of sections respectively corresponding to a plurality of parts of a body of the user, and includes an inner layer positioned on a side of the user and an outer layer positioned on a side opposite to the user when viewed from the inner layer, the blower unit blows air between the inner layer and the outer layer of each of the plurality of sections, and the control device controls air blowing performed by the blower unit for each of the sections.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 15, 2024
    Inventor: Shigekazu NAKATSUGAWA
  • Publication number: 20240042164
    Abstract: A bedding system includes: a bedding; an auxiliary mechanism that is incorporated in the bedding and is to assist change of a body position of the user, the auxiliary mechanism including a plurality of column members that are long along a thickness-wise direction of the bedding, are individually movable along the thickness-wise direction, and are arranged to be parallel to each other; and a first control unit that controls movement of each of the column members.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 8, 2024
    Inventor: Shigekazu NAKATSUGAWA
  • Patent number: 9695396
    Abstract: A normal regenerated tissue is formed by exposing to radiation a connective tissue or a supporting tissue originating in an organ to thereby form a feeder layer and then transplanting epithelial cells thereon to form a stratified structure. By conveniently and surely providing regenerated tissue by the 3-dimensional culture with the use of a human-origin normal tissue as a base, it is possible to construct systems for assessing effects and side effects of chemicals such as drugs or assessing sensitivities thereof with the use of regenerated tissues as models of corresponding tissues respectively.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: July 4, 2017
    Assignee: SHIGEKAZU NAKATSUGAWA
    Inventor: Shigekazu Nakatsugawa
  • Patent number: 8592176
    Abstract: A normal regenerated tissue is formed by exposing to radiation a connective tissue or a supporting tissue originating in an organ to thereby form a feeder layer and then transplanting epithelial cells thereon to form a stratified structure. By conveniently and surely providing regenerated tissue by the 3-dimensional culture with the use of a human-origin normal tissue as a base, it is possible to construct systems for assessing effects and side effects of chemicals such as drugs or assessing sensitivities thereof with the use of regenerated tissues as models of corresponding tissues respectively.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: November 26, 2013
    Assignee: Japan Science and Technology Corporation
    Inventor: Shigekazu Nakatsugawa
  • Patent number: 7910115
    Abstract: A polypeptide absorbable into digestive organs, which is linked with a bioactive polypeptide, and assists absorption of the bioactive polypeptide into digestive organs when it is orally taken; a fusion polypeptide comprising the polypeptide absorbable into digestive organs and the bioactive polypeptide; and an oral composition comprising the fusion polypeptide are provided.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: March 22, 2011
    Inventors: Shigekazu Nakatsugawa, Hideaki Nakamura
  • Publication number: 20070183975
    Abstract: A polypeptide absorbable into digestive organs, which is linked with a bioactive polypeptide, and assists absorption of the bioactive polypeptide into digestive organs when it is orally taken; a fusion polypeptide comprising the polypeptide absorbable into digestive organs and the bioactive polypeptide; and an oral composition comprising the fusion polypeptide are provided.
    Type: Application
    Filed: April 30, 2004
    Publication date: August 9, 2007
    Inventors: Shigekazu Nakatsugawa, Hideaki Nakamura
  • Publication number: 20040241837
    Abstract: A normal regenerated tissue is formed by exposing to radiation a connective tissue or a supporting tissue originating in an organ to thereby form a feeder layer and then transplanting epithelial cells thereon to form a stratified structure. By conveniently and surely providing regenerated tissue by the 3-dimensional culture with the use of a human-origin normal tissue as a base, it is possible to construct systems for assessing effects and side effects of chemicals such as drugs or assessing sensitivities thereof with the use of regenerated tissues as models of corresponding tissues respectively.
    Type: Application
    Filed: June 9, 2004
    Publication date: December 2, 2004
    Inventor: Shigekazu Nakatsugawa
  • Patent number: 4434788
    Abstract: A nucleoside selected from the group consisting of 3'-deoxyguanosine and 3'-deoxyuridine enhances, when administered to a tumor-bearing animal under an anti-tumor treatment, the anti-tumor effect due to the anti-tumor treatment. The anti-tumor treatment comprises irradiation of a tumor site of the animal or administration of an anti-tumor agent to the animal.
    Type: Grant
    Filed: July 27, 1981
    Date of Patent: March 6, 1984
    Assignee: Yamasa Shoyu Kabushiki Kaisha
    Inventor: Shigekazu Nakatsugawa
  • Patent number: 4432348
    Abstract: A nucleotide selected from the group consisting of 3'-deoxyguanosine-5'-monophosphate, 3'-deoxyadenosine-5'-monophosphate and pharmaceutically-acceptable salts thereof enhances, when administered to a tumor-bearing animal under an anti-tumor treatment, the anti-tumor effect due to the anti-tumor treatment. The anti-tumor treatment comprises irradiation of a tumor site of the animal or administration of an anti-tumor agent to the animal.
    Type: Grant
    Filed: September 9, 1981
    Date of Patent: February 21, 1984
    Assignee: Yamasa Shoyu Kabushiki Kaisha
    Inventor: Shigekazu Nakatsugawa